DYRK1A and acute lymphoblastic leukemia: Based on these findings, we hypothesized that the induction of cell cycle arrest in KMT2A-R ALL cells after pharmacologic inhibition may be via DYRK1A inhibitor-mediated downregulation of ERK signaling.